Up-regulated expression of advanced glycation end-products and their receptor in the small intestine and colon of diabetic rats

Digestive Diseases and Sciences

Volumn 57, Issue 1, 2012, Pages 48-57

  Chen, Pengmin ^a,c   Zhao, Jingbo ^a,b   Gregersen, Hans ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

AGE; Colon; Diabetes; Immunohistochemistry; Intestine; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRUSH BORDER; COLON; CONTROLLED STUDY; EXCISION; EXPERIMENTAL DIABETES MELLITUS; GANGLION; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; INTESTINE VILLUS; JEJUNUM; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; SMALL INTESTINE; STAINING; TISSUE REGENERATION; UPREGULATION;

ANIMALS; COLON; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GASTROINTESTINAL DISEASES; GLYCOSYLATION END PRODUCTS, ADVANCED; ILEUM; JEJUNUM; MALE; MUSCLE, SMOOTH; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; STREPTOZOCIN; UP-REGULATION;

EID: 84856707228     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1951-0     Document Type: Article

References (44)

1. M Nair 2007 Diabetes mellitus, part 1: physiology and complications Br J Nurs 16 184 188 17363887
2. Horowitz M, Samsom M. Gastrointestinal function in diabetes mellitus. Chichester: Wiley; 2004.
3. J Zhao JB Frøkjaer AM Drewes N Ejskjaer 2006 Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus World J Gastroenterol 12 2846 2857 16718808 (Pubitemid 43805453)
4. R Singh A Barden T Mori L Beilin 2001 Advanced glycation end-products: a review Diabetologia 44 129 146 11270668 10.1007/s001250051591 1:CAS:528:DC%2BD3MXntlSltg%3D%3D (Pubitemid 32156196)
5. A Bierhaus PM Humpert M Morcos 2005 Understanding RAGE, the receptor for advanced glycation end products J Mol Med 83 876 886 16133426 10.1007/s00109-005-0688-7 1:CAS:528:DC%2BD2MXht1SksbjP (Pubitemid 41598688)
6. DM Stern SD Yan SF Yan AM Schmidt 2002 Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes Ageing Res Rev 1 1 15 12039445 10.1016/S0047-6374(01)00366-9 1:CAS:528:DC%2BD38XosVejsrY%3D (Pubitemid 38340348)
7. SY Goh ME Cooper 2008 Clinical review: the role of advanced glycation end products in progression and complications of diabetes J Clin Endocrinol Metab 93 1143 1152 18182449 10.1210/jc.2007-1817 1:CAS:528:DC%2BD1cXks1ahtb0%3D (Pubitemid 351519698)
8. T Kato T Yamashita A Sekiguchi, et al. 2008 AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat J Cardiovasc Electrophysiol 19 415 420 18298515 10.1111/j.1540-8167.2007.01037.x (Pubitemid 351457548)
9. BH Chen DY Jiang LS Tang 2006 Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes Life Sci 79 1040 1048 16674981 10.1016/j.lfs.2006.03.020 1:CAS:528:DC%2BD28XntlWqtrY%3D (Pubitemid 44067065)
10. T Sugiyama T Okuno M Fukuhara, et al. 2007 Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes Exp Eye Res 85 406 412 17678894 10.1016/j.exer.2007.06.008 1:CAS:528:DC%2BD2sXpt1SnsLg%3D (Pubitemid 47259058)
11. K Fukami S Yamagishi S Ueda S Okuda 2008 Role of AGEs in diabetic nephropathy Curr Pharm Des 14 946 952 18473844 10.2174/138161208784139710 1:CAS:528:DC%2BD1cXlslCitrg%3D (Pubitemid 351753281)
12. D Suzuki M Toyoda N Yamamoto, et al. 2006 Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy Intern Med 45 435 441 16679697 10.2169/internalmedicine.45.1557 (Pubitemid 43676579)
13. AL Tan JM Forbes ME Cooper 2007 AGE, RAGE, and ROS in diabetic nephropathy Seminars in Nephrology 27 130 143 17418682 10.1016/j.semnephrol. 2007.01.006 1:CAS:528:DC%2BD2sXlt1KrtL8%3D (Pubitemid 46550311)
14. G Basta 2008 Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications Atherosclerosis 196 9 21 17826783 10.1016/j.atherosclerosis.2007.07.025 1:CAS:528: DC%2BD1cXpt12ntg%3D%3D
15. M Peppa SA Raptis 2008 Advanced glycation end products and cardiovascular disease Curr Diabetes Rev 4 92 100 18473756 10.2174/157339908784220732 1:CAS:528:DC%2BD1cXntV2kur4%3D
16. X Ling R Nagai N Sakashita, et al. 2001 Immunohistochemical distribution and quantitative biochemical detection of advanced glycation end products in fetal to adult rats and in rats with streptozotocin- induced diabetes Lab Invest 81 845 861 11406646 1:CAS:528:DC%2BD3MXkvFemsro%3D (Pubitemid 32553406)
17. VM Bhor S Sivakami 2003 Regional variations in intestinal brush border membrane fluidity and function during diabetes and the role of oxidative stress and non-enzymatic glycation Mol Cell Biochem 252 125 132 14577585 10.1023/A:1025599126840 1:CAS:528:DC%2BD3sXmvFeqsb4%3D (Pubitemid 37220741)
18. PV Jeyabal R Kumar PR Gangula, et al. 2008 Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats Neurogastroenterol Motil 20 253 261 17971026 10.1111/j.1365-2982. 2007.01018.x 1:CAS:528:DC%2BD1cXjs1emsL0%3D (Pubitemid 351197395)
19. R Wada S Yagihashi 2005 Role of advanced glycation end products and their receptors in development of diabetic neuropathy Ann N Y Acad Sci 1043 598 604 16037282 10.1196/annals.1338.067 1:CAS:528:DC%2BD2MXpvVKqtbw%3D (Pubitemid 41123949)
20. N Nazratun AA Mahmood UR Kuppusamy, et al. 2006 Diabetes mellitus exacerbates advanced glycation end product accumulation in the veins of end-stage renal failure patients Vasc Med 11 245 250 17390548 10.1177/1358863x06072202 1:STN:280:DC%2BD2s7ovFOgsQ%3D%3D (Pubitemid 46470503)
21. C Esposito H Gerlach J Brett, et al. 1989 Endothelial receptor-mediated binding of glucose modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties J Exp Med 170 1387 1407 2551990 10.1084/jem.170.4.1387 1:CAS:528:DyaL1MXmtFaqs7s%3D (Pubitemid 19250701)
22. AM Schmidt O Hori J Brett, et al. 1994 Cellular receptors for advanced glycation endproducts: implications for induction of oxidative stress and cellular dysfunction in the pathogenesis of vascular lesions Arterioscler Thromb 14 1521 1528 7918300 10.1161/01.ATV.14.10.1521 1:CAS:528:DyaK2cXmvFyjsLg%3D
23. H Vlassara 1991 Receptor mediated interactions of advanced glycosylation endproducts with cellular components within diabetic tissues Diabetes 41 52 56
24. H Vlassara R Bucala LJ Striker 1994 Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging Lab Invest 70 138 151 8139257 1:CAS:528:DyaK2cXksFCksLg%3D (Pubitemid 24090096)
25. SA Zoubi TM Mayhew RA Sparrow 1995 The small intestine in experimental diabetes: cellular adaptation in crypts and villi at different longitudinal sites Virchows Arch 426 501 507 7633660 10.1007/BF00193174 1:STN:280: DyaK2MzmtVaksQ%3D%3D
26. TM Mayhew FL Carson 1995 Mechanisms of adaptation in rat small intestine: regional differences in quantitative morphology during normal growth and experimental hypertrophy J Anat 164 189 200
27. G Zhou C Li L Cai 2004 Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor β-independent pathway Am J Pathol 165 2033 2043 15579446 10.1016/S0002-9440(10)63330-5 1:CAS:528:DC%2BD2MXhs1KnsQ%3D%3D (Pubitemid 39578381)
28. T Murata R Nagai T Ishibashi, et al. 1997 The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas Diabetologia 40 764 769 9243096 10.1007/s001250050747 1:CAS:528:DyaK2sXksFemsr4%3D (Pubitemid 27306953)
29. JR Rumble ME Cooper T Soulis, et al. 1997 Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products J Clin Invest 99 1016 1027 9062360 10.1172/JCI119229 1:CAS:528:DyaK2sXhs1Kqu74%3D (Pubitemid 27123639)
30. MD Oldfield LA Bach JM Forbes, et al. 2001 Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE) J Clin Invest 108 1853 1863 11748269 1:CAS:528:DC%2BD3MXpt1Ojt78%3D (Pubitemid 34015131)
31. N Seki N Hashimoto H Sano, et al. 2003 Mechanisms involved in the stimulatory effect of advanced glycation end products on growth of rat aortic smooth muscle cells Metabolism 52 1558 1563 14669155 10.1016/j.metabol.2003.07. 010 1:CAS:528:DC%2BD3sXpsVSnurw%3D (Pubitemid 38049271)
32. JT Handa KM Reiser H Matsunaga LM Hjelmeland 1998 The advanced glycation endproduct pentosidine induces the expression of PDGF-B in human retinal pigment epithelial cells Exp Eye Res 66 411 419 9593635 10.1006/exer.1997.0442 1:CAS:528:DyaK1cXjtlWgsrw%3D (Pubitemid 28206775)
33. B Chandrasekharan S Srinivasan 2007 Diabetes and the enteric nervous system Neurogastroenterol Motil 19 951 960 17971027 1:STN:280: DC%2BD2sjgvFegtQ%3D%3D (Pubitemid 350198313)
34. Guyton AC, Hall JE. Textbook of medical physiology. 10th ed. USA: W.B. Saunders Company; 2000:754-763.
35. TA Brasitus PK Dudeja 1985 Correction of abnormal lipid fluidity and composition of rat ileal microvillus membranes in chronic streptozotocin induced diabetes by insulin therapy J Biol Chem 260 12405 12409 3900076 1:CAS:528:DyaL2MXlslKmsrY%3D (Pubitemid 16233439)
36. WA Olsen H Korsmo 1977 The intestinal brush border membrane in diabetes. Studies of sucrase-isomaltase metabolism in rats with streptozotocin diabetes J Clin Invest 60 181 188 141462 10.1172/JCI108755 1:CAS:528:DyaE2sXkvVantr4%3D (Pubitemid 8145156)
37. M Keelan K Walker AB Thomson 1985 Intestinal brush border membrane marker enzymes, lipid composition and villus morphology: effect of fasting and diabetes mellitus in rats Comp Biochem Physiol A Comp Physiol 82 83 89 2864216 10.1016/0300-9629(85)90708-X 1:STN:280:DyaL28%2FgtlCgtg%3D%3D
38. LK Phillips CK Rayner KL Jones M Horowitz 2006 An update on autonomic neuropathy affecting the gastrointestinal tract Curr Diab Rep 6 417 423 17118223 10.1007/s11892-006-0073-0 1:CAS:528:DC%2BD2sXjvFertQ%3D%3D (Pubitemid 44896400)
39. RH King 2001 The role of glycation in the pathogenesis of diabetic polyneuropathy Mol Pathol 54 400 408 11724915 1:CAS:528:DC%2BD38XnvFSjsbo%3D (Pubitemid 34025255)
40. KC Sourris JM Forbes 2009 Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy-are these receptors valid therapeutic targets Curr Drug Targets 10 42 50 19149535 10.2174/138945009787122905 1:CAS:528: DC%2BD1MXks1Cgsb8%3D
41. C Toth J Martinez DW Zochodne 2007 RAGE, diabetes, and the nervous system Curr Mol Med 7 766 776 18331235 10.2174/156652407783220705 1:CAS:528: DC%2BD1cXhvF2hu7w%3D
42. A Russo R Fraser K Adachi, et al. 1999 Evidence that nitric oxide mechanisms regulate small intestinal motility in humans Gut 44 72 76 9862828 10.1136/gut.44.1.72 1:CAS:528:DyaK1MXpvVOmsg%3D%3D (Pubitemid 29143282)
43. K Korenaga MA Micci G Taglialatela PJ Pasricha 2006 Suppression of nNOS expression in rat enteric neurones by the receptor for advanced glycation end-products Neurogastroenterol Motil 18 392 400 16629867 10.1111/j.1365-2982. 2006.00774.x 1:STN:280:DC%2BD283isFChsg%3D%3D
44. C Toth LL Rong C Yang, et al. 2008 Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy Diabetes 57 1002 1017 18039814 10.2337/db07-0339 1:CAS:528:DC%2BD1cXksVGku74%3D